Skip to main content
Clinical Trials/NCT04936451
NCT04936451
Terminated
Not Applicable

Contribution of an Electrotherapy Technique Such as TENS ECOMODYN® vs Electrotherapy Only Type TENS in the Management of Myofascial Syndrome After Breast Surgery

Institut Cancerologie de l'Ouest1 site in 1 country5 target enrollmentJanuary 5, 2022
ConditionsBreast Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Institut Cancerologie de l'Ouest
Enrollment
5
Locations
1
Primary Endpoint
The main objective is to evaluate the effectiveness of TENS and TENS ECOMODYN® on the management of chronic breast pain after surgery.
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

Myofascial syndrome is defined as "musculoskeletal pain characterized by local and referred pain perceived to be deep and constant, and by the presence of myofascial trigger points in any part of the body" Post-breast surgery myofascial syndrome affects up to 44.7% of operated women, mainly on the muscles of the greater shoulder girdle. The repercussions are significant, functional, somatic, psychological and socio-professional affecting the quality of life. The treatments offered may or may not be medicinal. Transcutaneous electrical nerve stimulation (TENS) is a therapy that uses low voltage electrical current to provide pain relief. A TENS unit consists of a battery-powered device that delivers electrical impulses through electrodes placed on the surface of your skin. The electrodes are placed at or near nerves where the pain is located or at trigger points.

Registry
clinicaltrials.gov
Start Date
January 5, 2022
End Date
April 14, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Institut Cancerologie de l'Ouest
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female who had first breast cancer surgery, regardless of the type of surgery
  • Age ≥ 18 years
  • Patients with refractory pain with myofascial syndrome, with a numerical scale ≥ 4
  • Topical treatment for refractory pain completed more than 30 days ago
  • Healthy, non-irritated skin on painful areas to treat
  • Patient with a third party who can attend visits M0 and M2.5
  • Obtaining the signed written consent of the patient
  • Major patient affiliated to a social security scheme

Exclusion Criteria

  • Patient who has used TENS before on the muscles affected by the myofascial syndrome
  • Post-surgery management of the affected area by a physiotherapist
  • Person with venous thrombosis
  • Contraindications specific to the treatments studied

Outcomes

Primary Outcomes

The main objective is to evaluate the effectiveness of TENS and TENS ECOMODYN® on the management of chronic breast pain after surgery.

Time Frame: 16,5 months

Chronic pain is assessed using the Digital Pain Rating Scale (0 worse outcome to 10 better outcome) before and after using the method (TENS and TENS ECOMODYN®) at M0, M2, M2.5 and M4.5.

Secondary Outcomes

  • Evaluate the changes made by the treatment felt by the patient(16.5 months)

Study Sites (1)

Loading locations...

Similar Trials